Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study
Haemophilia · 2026-11 · 32 (6) · 1548-1553
DOI: 10.1111/hae.70228 ↗Kurz gefasst
Leserbrief in der Zeitschrift Haemophilia, online erschienen am 04.08.2026. Verfasst von Erin Cockrell und 18 weiteren Autor:innen. Beteiligte Einrichtung: St. Joseph's Hospital Center for Bleeding and Clotting Disorders, Tampa, Florida, USA. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Thrombosis and Hemostasis Network.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- St. Joseph's Hospital Center for Bleeding and Clotting Disorders, Tampa, Florida, USA.
- American Thrombosis and Hemostasis Network, Hickory, North Carolina, USA.
- Louisiana Comprehensive Hemophilia Center, Tulane University Medical Center, New Orleans, Louisiana, USA.
- Boston Bleeding Disorders Center, Boston Children's Hospital, Boston, Massachusetts, USA.
- Children's National Medical Center, Hemophilia Treatment Center, Washington, District of Columbia, USA.
- Oklahoma Center for Bleeding and Clotting Disorders, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA.
Förderung
- American Thrombosis and Hemostasis Network
Zitieren
APA
Cockrell, E., Chandler, M., Chrisentery-Singleton, T., Croteau, S. E., Daoud, N., Guerrera, M. F., Hirsh, M. N., Journeycake, J., Kulkarni, R., Lattimore, S. U., McGuinn, C., Ragni, M., Recht, M., Reiss, U. M., Sidonio, R., Takemoto, C. M., Tarantino, M., von Drygalski, A., & Neufeld, E. J. (2026). Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study. Haemophilia, 32(6), 1548-1553. https://doi.org/10.1111/hae.70228
Vancouver
Cockrell E, Chandler M, Chrisentery-Singleton T, Croteau SE, Daoud N, Guerrera MF, et al. Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study. Haemophilia. 2026;32(6):1548-1553. doi:10.1111/hae.70228
BibTeX
@article{Cockrell2026,
author = {Cockrell, Erin and Chandler, Martin and Chrisentery-Singleton, Tammuella and Croteau, Stacy E and Daoud, Nabil and Guerrera, Michael F and Hirsh, M Nikki and Journeycake, Janna and Kulkarni, Roshni and Lattimore, Susan U and McGuinn, Catherine and Ragni, Margaret and Recht, Michael and Reiss, Ulrike M and Sidonio, Robert and Takemoto, Cliffford M and Tarantino, Michael and von Drygalski, Annette and Neufeld, Ellis J},
title = {Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study},
journal = {Haemophilia},
year = {2026},
volume = {32},
number = {6},
pages = {1548--1553},
doi = {10.1111/hae.70228}
}
EUVIMED